United States · Series B startup
2 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 3 months ago
Follow Crystalys Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$335Mraised across 2 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Frazier Life SciencesLead
Wellington Management
Novo Holdings
Cormorant Asset Management
SR One
Pivotal bioVenture Partners
Soleus Capital
Catalys Pacific
KCap Biotechnology Fund LP
Trails Edge Capital PartnersReported by Frazier Life Sciences and 1 other
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Crystalys Therapeutics's investors include Novo Holdings, SR One, Frazier Life Sciences, Wellington Management and Cormorant Asset Management, and 8 more on record. Frazier Life Sciences led its latest round.
Crystalys Therapeutics has raised $335M across 2 rounds since 2025.
Crystalys Therapeutics's most recent round was a Series B of $130M in Jul 2026, led by Frazier Life Sciences.
Crystalys Therapeutics's largest round on record is $205M (Series A), in Sept 2025.
Crystalys Therapeutics's first round on record, in Sept 2025, was backed by Novo Holdings, SR One and Alexandria Venture Investments and 1 others.
Crystalys Therapeutics's latest named round is a Series B, in Jul 2026.
Crystalys Therapeutics is based in the United States.
Frazier Life Sciences led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
